U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 32

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:17211793
GRCh38:
Chr16:17117936
XYLT1F756CDesbuquois dysplasia 2Uncertain significancecriteria provided, single submitter
2.
GRCh37:
Chr16:17294463
GRCh38:
Chr16:17200606
XYLT1M321RDesbuquois dysplasia 2Uncertain significance
(Aug 26, 2020)
criteria provided, single submitter
3.
GRCh37:
Chr16:17202664
GRCh38:
Chr16:17108807
XYLT1G923DDesbuquois dysplasia 1, Desbuquois dysplasia 2Uncertain significance
(Aug 5, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr16:17221755
GRCh38:
Chr16:17127898
XYLT1not provided, Desbuquois dysplasia 2Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr16:17294295
GRCh38:
Chr16:17200438
XYLT1not provided, Desbuquois dysplasia 2Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr16:17232325
GRCh38:
Chr16:17138468
LOC102723692, XYLT1R551Cnot provided, Desbuquois dysplasia 2Pathogenic
(Apr 17, 2023)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr16:17228363
GRCh38:
Chr16:17134506
XYLT1, LOC102723692T665MDesbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr16:17211848
GRCh38:
Chr16:17117991
XYLT1Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr16:17292074
GRCh38:
Chr16:17198217
XYLT1Desbuquois dysplasia 2, Desbuquois dysplasia 1, not provided
Benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr16:17211729
GRCh38:
Chr16:17117872
XYLT1Desbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr16:17211545
GRCh38:
Chr16:17117688
XYLT1V839Inot provided, Desbuquois dysplasia 1, Desbuquois dysplasia 2
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr16:17353090
GRCh38:
Chr16:17259233
XYLT1A223GDesbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr16:17228368
GRCh38:
Chr16:17134511
XYLT1, LOC102723692Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr16:17202757
GRCh38:
Chr16:17108900
XYLT1R892QDesbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr16:17202801
GRCh38:
Chr16:17108944
XYLT1Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr16:17352836
GRCh38:
Chr16:17258979
XYLT1Desbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
Benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr16:17294348
GRCh38:
Chr16:17200491
XYLT1not provided, Desbuquois dysplasia 2, Desbuquois dysplasia 1
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr16:17292142
GRCh38:
Chr16:17198285
XYLT1R406WDesbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
Uncertain significance
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr16:17202777
GRCh38:
Chr16:17108920
XYLT1Desbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr16:17252767
GRCh38:
Chr16:17158910
XYLT1Desbuquois dysplasia 2Pathogenic
(Feb 28, 2019)
no assertion criteria provided
21.
GRCh37:
Chr16:17564348-17564373
GRCh38:
Chr16:17470491-17470516
XYLT1Q94fsDesbuquois dysplasia 2Pathogenic
(Feb 28, 2019)
no assertion criteria provided
22.
GRCh38:
Chr16:472169
XYLT1Desbuquois dysplasia 2Pathogenic
(Nov 7, 2019)
no assertion criteria provided
23.
GRCh37:
Chr16:17564335
GRCh38:
Chr16:17470478
XYLT1G107*Desbuquois dysplasia 2Pathogenic
(Feb 28, 2019)
no assertion criteria provided
24.
GRCh37:
Chr16:17232220
GRCh38:
Chr16:17138363
LOC102723692, XYLT1R586CDesbuquois dysplasia 1, Pseudoxanthoma elasticum, Desbuquois dysplasia 2
Uncertain significance
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr16:17232242-17232243
GRCh38:
Chr16:17138385-17138386
LOC102723692, XYLT1not providedPathogenic
(Apr 20, 2017)
criteria provided, single submitter
26.
GRCh37:
Chr16:17252768
GRCh38:
Chr16:17158911
XYLT1Desbuquois dysplasia 2Pathogenic
(Mar 6, 2014)
no assertion criteria provided
27.
GRCh37:
Chr16:17232391
GRCh38:
Chr16:17138534
LOC102723692, XYLT1Desbuquois dysplasia 2, Pseudoxanthoma elasticum, not provided,
Desbuquois dysplasia 1
Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr16:17564377-17564378
GRCh38:
Chr16:17470520-17470521
XYLT1P93fsDesbuquois dysplasia 2Pathogenic
(Mar 6, 2014)
no assertion criteria provided
29.
GRCh37:
Chr16:17353319
GRCh38:
Chr16:17259462
XYLT1, LOC130058566R147*Desbuquois dysplasia 2Pathogenic
(Mar 6, 2014)
no assertion criteria provided
30.
GRCh37:
Chr16:17228565
GRCh38:
Chr16:17134708
XYLT1, LOC102723692R598CDesbuquois dysplasia 1Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr16:17235156
GRCh38:
Chr16:17141299
XYLT1R481WDesbuquois dysplasia 2Pathogenic
(Jan 1, 2014)
no assertion criteria provided
32.
GRCh37:
Chr16:17564311
GRCh38:
Chr16:17470454
XYLT1A115SDesbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination